RESUMEN
Assembly of C5b-9 on cell membranes results in transmembrane channels and causes cell death. When the number of C5b-9 molecules is limited, nucleated cells are able to escape cell death by endocytosis and by shedding of membranes bearing C5b-9. Sublytic CSb-9 induces proto-oncogenes, activates the cell cycle, and enhances cell survival. In addition, C5b-9 reverses the differentiated phenotype of postmitotic cells, such as oligodendrocytes and skeletal muscle cells. The signal transduction pathways responsible for cell cycle activation by CSb-9 include Gi-mediated activation of extracellular signal-regulated kinase 1 and phosphatidylinositol 3-kinase (PI3-K). Cell survival enhanced by C5b-9 is mediated by the PI3-K/Akt pathway, which inhibits apoptosis through regulation of BAD. These findings indicate that complement activation and membrane assembly of sublytic C5b-9 play an important role in inflammation by promoting cell proliferation and by rescuing apoptotic cells.
Asunto(s)
Apoptosis/fisiología , Ciclo Celular/fisiología , Complejo de Ataque a Membrana del Sistema Complemento/fisiología , Proteínas Serina-Treonina Quinasas , Animales , Proteínas Portadoras/fisiología , Diferenciación Celular/fisiología , Permeabilidad de la Membrana Celular , Endocitosis , Regulación de la Expresión Génica/fisiología , Humanos , Sistema de Señalización de MAP Quinasas/fisiología , Mitocondrias/fisiología , Proteína Quinasa 3 Activada por Mitógenos , Proteínas Quinasas Activadas por Mitógenos/fisiología , Necrosis , Fosfatidilinositol 3-Quinasas/fisiología , Proteínas Proto-Oncogénicas/fisiología , Proteínas Proto-Oncogénicas c-akt , Proteínas Proto-Oncogénicas c-bcl-2/fisiología , Proto-Oncogenes , Proteína de Retinoblastoma/fisiología , Proteína X Asociada a bcl-2 , Proteína Letal Asociada a bcl , Proteína bcl-XRESUMEN
Interleukin 6 (IL-6) and interleukin 8 (IL-8) are present in the human arterial atherosclerotic wall as cellular and extracellular deposits in the connective tissue matrix. Quantitative determinations of IL-6 by ELISA showed mean values of 27.6 +/- 3.3 ng/100 mg protein in normal intima, 37.3 +/- 2.1 ng/100 mg protein in fibrous plaque and 25.7 +/- 4.3 ng/100 mg total extracted protein in media. IL-8 levels were 3.5 +/- 0.6 ng/100 mg protein in normal intima, 11.3 +/- 2.1 ng/100 mg protein in fibrous plaque and 8.5 +/- 1.4 ng/100 mg total extracted protein in media. Fibrous plaques presented statistically significant higher levels of both IL-6 and IL-8. IL-6 and IL-8 gene transcripts were present in human iliac fibrous plaque and media prelevated at surgery indicating that a local production by the cells of the arterial wall participate to their accumulation. We also tested the role of complement activation in induction of IL-6 and IL-8 protein synthesis as well as the subsequent activation of endothelial cells. Only IL-8 was induced by complement activation and this may contribute to increased IL-8 levels found in the atherosclerotic wall. When exposed to terminal complement complexes, endothelial cells in culture also showed an increase of both DNA-synthesis and p70 S6 kinase activity indicating that complement is able to induce not only IL-8 synthesis but also cell activation. The presence of IL-6 and IL-8 in the arterial wall where complement activation also occurred, clearly show the involvement of inflammatory events in initiation and progression of atherosclerosis.
Asunto(s)
Arteriosclerosis/metabolismo , Endotelio Vascular/metabolismo , Expresión Génica , Interleucina-6/biosíntesis , Interleucina-8/biosíntesis , ARN/análisis , Aorta/metabolismo , Aorta/patología , Arteriosclerosis/patología , Células Cultivadas , ADN/biosíntesis , Endotelio Vascular/patología , Ensayo de Inmunoadsorción Enzimática , Arteria Femoral/metabolismo , Arteria Femoral/patología , Humanos , Inmunohistoquímica , Interleucina-6/genética , Interleucina-8/genética , Persona de Mediana Edad , Sondas de Oligonucleótidos/química , Proteínas Serina-Treonina Quinasas/metabolismo , Proteínas Quinasas S6 RibosómicasRESUMEN
Sublytic complement attack on oligodendrocytes (OLG) by activation of terminal complement complexes (TCC) selectively enhances the decay of myelin protein mRNAs. We have investigated whether TCC also stimulate differentiated OLG to enter the cell cycle and whether the cell cycle induction is related to the oncogene expression. Complement activation and TCC assembly induced expression of c-jun, JunD, and c-fos mRNAs, increased AP-1 DNA-binding activity within 1 h, and increased [3H]thymidine uptake. The c-jun NH2-terminal kinase activity was increased to the maximum level 20 min after TCC assembly. The increase in thymidine uptake was inhibited by pretreatment of OLG with antisense c-jun oligonucleotides. Studies on cyclin-dependent kinase (cdk) activation revealed that complement increased cyclin-dependent cell cycle associated kinase-2 activity in G1, while cdk2 and cdk4 showed low activity during G1 progression. However, the activity of cdk4 complexed with cyclin D2 showed a marked increase in G1/S transition. Our data provide evidence that sublytic TCC stimulate OLG to enter the cell cycle by induction of c-jun through activation of the c-jun NH2-terminal kinase pathway. In addition, sublytic TCC assembly significantly reduced the number of OLG undergoing apoptotic cell death, which occurs spontaneously in defined medium. These changes together with enhanced degradation of myelin protein mRNA may represent a mechanism for differentiated primary OLG to respond to limited complement activation in inflammation.
Asunto(s)
Complejo de Ataque a Membrana del Sistema Complemento/administración & dosificación , Genes jun , Proteínas Quinasas Activadas por Mitógenos , Oligodendroglía/citología , Fase S/efectos de los fármacos , Animales , Apoptosis , Secuencia de Bases , Proteínas Quinasas Dependientes de Calcio-Calmodulina/genética , Células Cultivadas , Quinasas Ciclina-Dependientes/genética , Ciclinas/genética , ADN/biosíntesis , Cartilla de ADN/química , Relación Dosis-Respuesta Inmunológica , Expresión Génica , Proteínas Quinasas JNK Activadas por Mitógenos , Datos de Secuencia Molecular , Proteína Básica de Mielina/genética , Proteína Proteolipídica de la Mielina/genética , ARN Mensajero/genética , Ratas , Ratas Sprague-Dawley , Factor de Transcripción AP-1/metabolismoRESUMEN
Newcastle disease virus (NDV) induces tumour necrosis factor alpha (TNF alpha) gene transcription and increases the mRNA stability. NDV stabilizes TNF alpha mRNA by preventing poly(A) shortening in a protein kinase C-dependent manner. TNF alpha 3'-untranslated region (UTR) contains an AU-rich domain (ARD) with seven AUUUA pentamers, a motif implicated in poly(A) removal and mRNA degradation. In this report, protein binding to TNF alpha ARD and the effects of NDV and kinases on ARD-binding activity were investigated in primary rat astrocytes. Both nuclear and cytoplasmic extracts contained proteins binding to centrally located 27 nt AUUUAUUAUUUAUUUAUUAUUUAUUUA, within TNF alpha ARD. Portions of ARD with a single AUUUA did not show ARD-binding activity. The ARD-protein complexes migrated as two bands on electrophoretic mobility-shift assay. The slower moving complexes appeared either as a broader band or doublets. The UV cross-linked ARD-protein complexes, however, migrated as a single 35 kDa band on SDS/PAGE. In cytoplasmic extracts treated with alkaline phosphatase there was a decrease in the faster moving complex and an increase in the slower moving complex, whereas NDV infection produced the reverse effect. In addition, the faster moving complex was decreased when cytoplasmic extracts from NDV-infected cells were treated with protein phosphatase 1 or 2A. Neither NDV infection nor phosphatase treatment affected the mobility pattern of nuclear extracts. The data indicate that a protein of molecular mass less than 35 kDa binds to a segment of TNF alpha ARD containing primarily UUAUUUAUU motifs, and the ARD-binding activity in cytoplasmic compartment is post-transcriptionally modified.
Asunto(s)
Astrocitos/metabolismo , ARN Mensajero/química , ARN Mensajero/metabolismo , Proteínas de Unión al ARN/metabolismo , Factor de Necrosis Tumoral alfa/genética , 1-(5-Isoquinolinesulfonil)-2-Metilpiperazina , Fosfatasa Ácida/metabolismo , Fosfatasa Alcalina/metabolismo , Animales , Astrocitos/virología , Secuencia de Bases , Encéfalo/metabolismo , Núcleo Celular/metabolismo , Células Cultivadas , Citoplasma/metabolismo , Sondas de ADN , Inhibidores Enzimáticos/farmacología , Isoquinolinas/farmacología , Datos de Secuencia Molecular , Virus de la Enfermedad de Newcastle/fisiología , Piperazinas/farmacología , Poli U/farmacología , Proteína Quinasa C/antagonistas & inhibidores , ARN Mensajero/genética , Ratas , Ratas Sprague-Dawley , Rayos UltravioletaRESUMEN
Sublytic terminal C complexes (TCC) are capable of stimulating cells and affect the target cell activity. Activation of TCC that generates leukotriene B4 in oligodendrocytes, the myelin-forming cells of the central nervous system, is also a required process in antibody-mediated demyelination of rodent cerebellar explants. In the present study, the effect of TCC on myelin protein gene expression was studied in primary rat oligodendrocytes in culture. Sublytic activation of serum C reduced accumulation of mRNA encoding proteolipid protein (PLP) and myelin basic protein (MBP) within 1 h, but not beta-actin mRNA. C activation, on the other hand, induced sustained expression of c-jun mRNA. Experiments using C7-deficient human serum to determine the role of TCC showed that selective MBP and PLP mRNA down-regulation was achieved only when C7 was reconstituted to form TCC. The C7 requirement was also observed in the presence of alpha-amanitin. Post-transcriptional regulation was explored by determining mRNA decay, which demonstrated that the MBP and PLP mRNA were selectively destabilized when C7 was reconstituted. Limited exploration of the signals responsible for the TCC effect revealed that down-regulation of mRNA by TCC was significantly influenced by Ca2+ on PLP, whereas MBP did not show the same Ca2+ sensitivity as PLP. The TCC-mediated MBP mRNA decay was completely abrogated by HA1004, an inhibitor for the cAMP- and cGMP-dependent protein kinases, but not by H7, a protein kinase C inhibitor.
Asunto(s)
Proteínas del Sistema Complemento/fisiología , Proteínas de la Mielina/genética , Oligodendroglía/metabolismo , ARN Mensajero/metabolismo , Amanitinas/farmacología , Animales , Calcio/fisiología , Células Cultivadas , Expresión Génica/efectos de los fármacos , Genes jun , Técnicas In Vitro , Proteína Proteolipídica de la Mielina , Proteínas Quinasas/metabolismo , Ratas , Ratas Sprague-DawleyRESUMEN
The neoantigens of the C5b-9 complement complex, IgG, C3, C4, S-protein/vitronectin, fibronectin, and macrophages were localized on 17 samples of breast cancer and on 6 samples of benign breast tumors using polyclonal or monoclonal antibodies and the streptavidin-biotin-peroxidase technique. All the tissue samples with carcinoma in each the TNM stages presented C5b-9 deposits on the membranes of tumor cells, thin granules on cell remnants, and diffuse deposits in the necrotic areas. When chemotherapy and radiation therapy preceded surgery, C5b-9 deposits were more intense and extended. The C5b-9 deposits were absent in all the samples with benign lesions. S-protein/vitronectin was present as fibrillar deposits in the connective tissue matrix and as diffuse deposits around the tumor cells, less intense and extended than fibronectin. IgG, C3, and C4 deposits were present only in carcinoma samples. The presence of C5b-9 deposits is indicative of complement activation and its subsequent pathogenetic effects in breast cancer.
Asunto(s)
Neoplasias de la Mama/inmunología , Activación de Complemento , Fibrosis Quística/inmunología , Proteínas Sanguíneas/análisis , Neoplasias de la Mama/metabolismo , Neoplasias de la Mama/patología , Complemento C3/análisis , Complemento C4/análisis , Complemento C5/análisis , Complemento C5b , Fibrosis Quística/metabolismo , Fibrosis Quística/patología , Femenino , Glicoproteínas/análisis , Humanos , Inmunoglobulina G/análisis , Macrófagos/química , Persona de Mediana Edad , Células Tumorales Cultivadas , VitronectinaRESUMEN
Synthesis of complement proteins and their regulation in resident cells of the central nervous system are important pathophysiologic factors that can affect the outcome of inflammatory central nervous system diseases. Primary cultures of rat astrocytes constitutively express C3 mRNA and produce C3 protein; both of them were enhanced by LPS or by a live as well as inactivated Newcastle disease virus, a neurotropic paramixovirus. TNF, IL-1 beta, and IL-8 also increased the levels of C3 mRNA and protein whereas IL-1 alpha and IL-6 had no effect, although all of these cytokines are inducible by LPS. LPS stimulation in the presence of cycloheximide decreased the LPS-mediated C3 mRNA induction by 60%. These data suggest that LPS effect on C3 regulation is mediated directly by LPS as well as by LPS-induced cytokines. Interestingly, C3 mRNA induced by Newcastle disease virus or inactivated Newcastle disease virus was inhibited by protein kinase inhibitors, H-7 and staurosporine, whereas these inhibitors had no effect on C3 induction mediated by LPS or cytokines, indicating the existence of different signal transduction pathways.
Asunto(s)
Astrocitos/fisiología , Complemento C3/genética , Citocinas/farmacología , Enfermedad de Newcastle/inmunología , Virus de la Enfermedad de Newcastle/inmunología , Alcaloides/farmacología , Animales , Proteínas Portadoras/genética , Proteínas Inactivadoras del Complemento C3b/genética , Complemento C4/genética , Factor H de Complemento , Expresión Génica/efectos de los fármacos , Integrina alfaXbeta2 , Interleucina-1/farmacología , Interleucina-8/farmacología , Lipopolisacáridos/administración & dosificación , Proteína Quinasa C/antagonistas & inhibidores , ARN Mensajero/genética , Ratas , Estaurosporina , Factor de Necrosis Tumoral alfa/farmacologíaRESUMEN
Tumor necrosis factor-alpha (TNF-alpha) was demonstrated in human normal and atherosclerotic aorta, iliac and femoral arteries by immunohistochemistry using monoclonal and polyclonal antibodies. TNF was present in the cells of the arterial wall and as granular and diffuse extracellular deposits in the connective tissue matrix. Quantitative determinations of TNF by ELISA showed mean values of 21.7 +/- 0.7 ng/100 mg total extracted protein in normal intima, 38.2 +/- 0.5 in intimal thickenings, 25.5 +/- 1.1 in fibrous plaques and 16.8 +/- 0.2 ng/100 mg total extracted protein in media. Intimal thickenings presented the highest amounts of TNF with a statistically significant difference when compared to normal intima (P less than 0.05) and media (P less than 0.01). TNF-alpha concentrations in arterial eluates were about 200 times higher than in the corresponding serum samples. Western blotting analysis confirmed TNF-alpha eluted from the arterial wall to be about 17 kDa similar to human recombinant TNF-alpha. TNF-alpha in human atherosclerotic wall could be actively involved in the inflammatory events associated with atherosclerosis.
Asunto(s)
Arterias/metabolismo , Arteriosclerosis/metabolismo , Factor de Necrosis Tumoral alfa/metabolismo , Aorta/metabolismo , Ensayo de Inmunoadsorción Enzimática , Arteria Femoral/metabolismo , Humanos , Arteria Ilíaca/metabolismo , Immunoblotting , InmunohistoquímicaRESUMEN
The paper reviews data in the literature as well as the authors' own investigations, performed during the last seven years, concerning the hemostatic balance in nephrotic patients. The obviously increased plasma levels of fibrinogen, fibronectin, fibrin-stabilizing factor XIII, clotting factors V and VIII, von Willebrand factor as well as the enhanced platelet aggregability of such patients, associated with a decreased plasma antithrombin III, are compatible with a thrombotic tendency. On the other hand the increased plasma protein C may provide a compensative antithrombotic mechanism. A rather complex behaviour of the fibrinolytic system was noted in the nephrotic syndrome. Actually the enhanced release of tissue plasminogen activator (t-PA) from the endothelia of nephrotic patients is accompanied by an accelerated lysis of dilute blood clots, although the inhibitors of fibrinolysis such as alpha 2-macroglobulin and alpha 2-antiplasmin are increased. Failure or exhaustion of the compensative antithrombotic mechanisms would accentuate the hemostatic imbalance and favour the occurrence of thrombotic events. It is considered that increased urinary loss of antithrombin III and the enhanced hepatic synthesis of clotting factors would represent the main mechanisms involved in the production of this precarious hemostatic balance of nephrotic patients.
Asunto(s)
Hemostasis , Nefrosis/sangre , Antitrombina III/análisis , Factor XIII/análisis , Fibrinógeno/análisis , Fibrinólisis , Fibronectinas/sangre , Humanos , Nefrosis/etiología , Agregación Plaquetaria , Proteína C/análisis , Factor de von Willebrand/análisisRESUMEN
Decay-accelerating factor (DAF) is an intrinsic membrane inhibitor that regulates the activity of C3 and C5 convertases of the classical and alternative complement pathways. Using two monoclonal antibodies, IC6 and IA10, DAF was localized by immunohistochemistry using streptavidin-biotin-peroxidase complex or silver-intensified immunogold techniques in aortic, iliac and femoral samples obtained at surgery and autopsy from 32 patients. DAF was localized on the cells and in the connective tissue matrix of the arterial wall. Fibrous plaques and intimal thickenings presented larger amounts than fatty streaks, intimae and normal areas. By Western blotting analysis, DAF extracted from the arterial wall had a molecular weight of about 67 kDa. Using a double-labeling technique, DAF and C5b-9 complexes were co-localized on nucleated cells and on cell debris. The cells isolated after enzyme digestion of the arterial wall were tested for the protective role of DAF to complement-mediated damage. When DAF of the sensitized cells was blocked by monoclonal antibodies, complement-mediated cell lysis was enhanced from 10-15% to 60-70%. The effect of anti-DAF antibodies was dose-dependent. DAF blocking in the absence of antibodies used for sensitization led to a lysis under 10%. These data suggest a protective role of DAF against autologous complement activation, however insufficient to prevent complement activation in the human atherosclerotic wall.
Asunto(s)
Arteriosclerosis/inmunología , Vasos Sanguíneos/inmunología , Complejo de Ataque a Membrana del Sistema Complemento/inmunología , Proteínas de la Membrana/fisiología , Adulto , Anciano , Anticuerpos Monoclonales/inmunología , Arteriosclerosis/metabolismo , Western Blotting , Antígenos CD55 , Citotoxicidad Inmunológica/inmunología , Humanos , Técnicas para Inmunoenzimas , Proteínas de la Membrana/metabolismo , Persona de Mediana EdadRESUMEN
S-protein/vitronectin is a multifunctional glycoprotein interacting with both complement activation and coagulation pathways. Its presence was investigated in 5 femoral and 5 iliac atherosclerotic human arteries, obtained at surgery, by immunoelectron microscopy using an affinity purified rabbit IgG specific for human S-protein/vitronectin. The immunoelectron dense specific deposits were found in both intimal thickenings and fibrous plaques in association with elastic fibers, collagen bundles and cell debris in the vicinity of elastin. Cell debris embedded in the collagen matrix were S-protein/vitronectin negative. S-protein/vitronectin was also absent on intact cells, lipid droplets and cholesterol clefts. All cell debris, however, was positive for C5b-9 deposits suggesting that complement activation had occurred at these sites with or without S-protein/vitronectin interaction. S-protein/vitronectin may play a role in the arterial wall defence by restricting the extent of complement activation.
Asunto(s)
Arteriosclerosis/patología , Glicoproteínas/metabolismo , Arteriosclerosis/metabolismo , Complejo de Ataque a Membrana del Sistema Complemento , Proteínas del Sistema Complemento/metabolismo , Tejido Conectivo/metabolismo , Tejido Conectivo/patología , Humanos , Técnicas para Inmunoenzimas , Masculino , Microscopía Electrónica , Persona de Mediana Edad , VitronectinaRESUMEN
Anti-carcinoembryonic (CEA) polyclonal antibodies in sheep and rabbits were raised using purified CEA from acid extracts of human colon adenocarcinoma. CEA was purified by gel filtration on Sepharose 4B CL and chromatography on DEAE-Sephadex A50. The antiserum was adsorbed with human serum and perchloric acid extract from normal colon. Anti-CEA IgG was purified from monospecific antiserum by ion-exchange chromatography and its specificity was tested on cryostat sections from colon adenocarcinoma by the indirect immunoperoxidase technique. The specific reaction was compared with that obtained by using a similar technique and two CEA specific monoclonal antibodies. An anti-CEA IgG peroxidase conjugate was obtained allowing to establish a "sandwich" ELISA-CEA system with two antibodies. CEA determinations were made in a group of 15 normal controls (mean value 4.8 +/- 0.4 ng/ml) and in 30 colorectal tumor patients (mean value 26.6 +/- 2.15 ng/ml). The anti-CEA antibodies are proven useful in immunocytochemical and ELISA techniques and may be further used in radioimaging of tumors.
Asunto(s)
Antígeno Carcinoembrionario/aislamiento & purificación , Inmunoglobulina G/aislamiento & purificación , Adenocarcinoma/inmunología , Animales , Antígeno Carcinoembrionario/análisis , Antígeno Carcinoembrionario/inmunología , Neoplasias del Colon/inmunología , Ensayo de Inmunoadsorción Enzimática/métodos , Humanos , Técnicas para Inmunoenzimas , Inmunoglobulina G/análisis , Inmunohistoquímica , Conejos , OvinosRESUMEN
Carcinoembryonic anti-antigen (CEA) polyclonal antibodies were obtained in ram and rabbit using as antigen source the extracts with perchloric acid from the human colon adenocarcinomas. CEA was purified by gel filtration on Sepharose 4BCL and ion-exchange chromatography (DEAE-Sephadex A50). The total antiserum was absorbed with human serum and perchloric acid extract from the normal colon. IgG anti-CEA was purified by chromatography of the monospecific antiserum, then tested for bonding specificity, at cryostat on sections of colon adenocarcinoma, by indirect immunoperoxidase. The specific reaction was compared with that obtained by the same technique, using two monoclonal antibodies specific to the CEA molecule (MAb-26/3/13 and MAb-26/5/1 respectively). IgG anti-CEA was also used for obtaining some IgG-peroxidase conjugates, with an immunoenzymatic system, ELISA type, with two antibodies according to the model of the ELISA kits produced by the Cantacuzino Institute (ELISA-AFP). The ELISA-CEA kit was standardized using an international CEA standard. CEA was quantitatively determined with this immunoenzymatic system (ELISA-CEA) on a group of 15 healthy subjects (average: 4.8 +/- 0.12 ng/ml) and on 30 patients with colorectal tumours (average: 26.6 +/- 0.15 ng/ml). ELISA-CEA kit, sensitive and reproducible, allow the usual quantitative determination of CEA, a useful marker in diagnosing and monitoring tumour evolution.
Asunto(s)
Antígeno Carcinoembrionario/inmunología , Ensayo de Inmunoadsorción Enzimática/métodos , Inmunoglobulinas/aislamiento & purificación , Especificidad de Anticuerpos/inmunología , Antígeno Carcinoembrionario/análisis , Neoplasias Colorrectales/diagnóstico , Neoplasias Colorrectales/inmunología , Humanos , Inmunohistoquímica/métodos , Juego de Reactivos para DiagnósticoRESUMEN
When compared to normal weight normolipidemic control subjects, dilute blood clot lysis time was found to be obviously (p less than 0.001) prolonged in hypertriglyceridemic patients without proteinuria and slightly (p less than 0.05) accelerated in hyperlipidemic nephrotic patients in spite of their very high levels of plasma fibrinogen. As a result the ratio plasma fibrinogen (mg/dl) per clot lysis time (minutes) was 1.241 +/- 0.08 (X +/- SEM) in control subjects, 0.574 +/- 0.07 in hypertriglyceridemic patients and 2.69 +/- 0.172 in nephrotic patients. This finding suggesting that a larger amount of fibrin is rather readily dispersed from dilute blood clots of nephrotic patients was associated with higher levels of plasma t-PA:Ag (9.45 ng/ml +/- 1.18 in nephrotic patients versus 5.8 ng/ml +/- 1.23 in controls before venous occlusion and respectively 33.1 ng/ml +/- 3.83 versus 20.3 +/- 3.40 in controls after venous occlusion). Plasminogen activator activity of the euglobulins as assessed by the bovine fibrin-agarose plate was significantly higher in nephrotic patients only after venous occlusion. Plasma samples of nephrotic patients exerted a more potent inhibition of fibrinolysis in a urokinase activated system. This effect was, however, mainly due to the high levels of alpha 2 macroglobulin in nephrotic plasma which apparently have little influence on dilute blood clot lysis time.
Asunto(s)
Nefrosis/sangre , Activador de Tejido Plasminógeno/análisis , Adolescente , Adulto , Anciano , Antígenos/análisis , Pruebas de Coagulación Sanguínea , Colesterol/sangre , Colinesterasas/sangre , Femenino , Fibrinógeno/metabolismo , Humanos , Hiperlipoproteinemias/sangre , Masculino , Persona de Mediana Edad , Activador de Tejido Plasminógeno/inmunología , Triglicéridos/sangreRESUMEN
After a short history and definition of the heterophile antibodies (antibodies in the IgM class, reacting to the antigenic determinants common to several species of animals) the paper reports on the antigens generating heterophile antibodies: the Forssman antigen, the Hanganutziu-Deicher antigen, the Paul-Brunnell antigen, respectively. Data are presented on the structure of these antigens and the important in diagnosing the heterophile antibodies in a series of diseases: malignant tumours, lymphomas, leukemias, infections mononucleosis, rheumatoid polyarthritis, Kawasaki's disease, Marek's disease.
Asunto(s)
Anticuerpos Heterófilos/inmunología , Animales , Anticuerpos Heterófilos/análisis , Antígenos Heterófilos/inmunología , Antígenos de Superficie/inmunología , Antígeno de Forssman/inmunología , Humanos , Pruebas SerológicasRESUMEN
Fibrous plaques and intimal thickenings of 5 femoral and 5 iliac human arteries obtained at surgery were processed for indirect and double-labeling immunoelectron microscopy using an affinity purified rabbit IgG anti-C5b-9 neoantigen and the EBM 11 monoclonal antibody anti-human macrophages. The C5b-9 complexes were localized in intact cells, disintegrated cells and cell debris enmeshed in the connective tissue matrix. Some of the cell debris bearing C5b-9 deposits was found to be of macrophage origin. Endocyted or exocyted pieces of membrane with pore-forming C5b-9 complexes were also identified. Damage of cells by complement in atherosclerotic lesions may contribute to atherogenesis.
Asunto(s)
Arteriosclerosis/inmunología , Proteínas del Sistema Complemento/inmunología , Anticuerpos Monoclonales , Complejo de Ataque a Membrana del Sistema Complemento , Arteria Femoral/inmunología , Arteria Femoral/ultraestructura , Humanos , Arteria Ilíaca/inmunología , Arteria Ilíaca/ultraestructura , Macrófagos/citologíaRESUMEN
The relationship between macrophages and the terminal C5b-9 complement complexes was investigated in human arteries affected with atherosclerosis by using monoclonal antibodies and indirect immunoperoxidase, immunogold silver staining, and double-labeling immunohistochemical techniques. Macrophages were found in all the atherosclerotic arteries as immunoreactive deposits with a nucleus, considered as intact cells, or without a nucleus, considered as cell remnants. The double-labeling technique shows C5b-9 deposits partially colocalized on the intact macrophages or on the cell debris of macrophage origin. These data suggest that C5b-9 complement complex may be formed on activated or dying macrophages with subsequent promotion of inflammatory events and progression of the atherosclerotic lesions.